Kim Forest Enterprise Co (金萬林), which focuses on molecular testing, reported that its revenue for the previous quarter grew 2.37 times from a year earlier to NT$212.29 million (US$7.57 million) on the back of strong demand for COVID-19 testing.
That buoyed cumulative revenue for the first three quarters of this year to NT$458 million, up 121 percent from a year earlier, the company said in a statement last week.
Local COVID-19 infections have slowed since July. However, demand for testing kits remains strong at hospitals and testing centers, the company said, adding that people working at hospitals, healthcare institutions and airports need